Seminars in Oncology
Volume 29, Issue 4 , Pages 353-360 , August 2002

The role of ultrasound in detection and management of regional disease in melanoma patients

References 

  1. Sim FH, Taylor WF, Ivins JC, et al.  A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer. 1978;41:948–956
  2. Balch CM, Soong SJ, Murad TM, et al.  A multifactorial analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg. 1981;193:377–388
  3. Veronesi U, Adamus J, Bandeira DC, et al.  Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420–2430
  4. Cascinelli N, Bufalino R, Marolda R, et al.  Regional non-nodal metastases of cutaneous melanoma. Eur Surg Oncol. 1986;12:175–180
  5. Singletary SE, Tucker SL, Boddie AW. Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer. 1988;61:1437–1440
  6. Morton DL, Wanek L, Nizze JA, et al.  Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg. 1991;214:491–499
  7. Balch CM, Soong SW, Shaw HM. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: ed 2.  Balch CM,  Houghton AN,  Milton GW, et al. editor. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. Philadelphia, PA: Lippincott; 1992;p. 165–187
  8. Balch CM, Soong SJ, Bartolucci AA, et al.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255–263
  9. Buzell RA, Zitelli JA. Favorable prognostic factors in recurrent and metastatic melanoma. J Am Acad Dermatol. 1996;34:798–803
  10. Balch CM, Cascinelli N, Sim FH, et al.  Elective lymph node dissection: Results of prospective randomized trials. In: ed 3.  Balch CM,  Houghton AN,  Sober AJ, et al. editor. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. St Louis, MO: Quality Medical Publishing; 1998;p. 209–225
  11. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel node in a feline model. Ann Surg. 1991;214:637–641
  12. Morton DL, Wen D-R, Wong JH, et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  13. Morton DL, Wen D-R, Forshag LJ, et al.  Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stage melanomas of the head and neck. J Clin Oncol. 1993;11:1751–1756
  14. Krag DN, Meijer SJ, Weaver DL, et al.  Minimal access surgery for staging malignant melanoma. Arch Surg. 1995;130:654–658
  15. Albertini JJ, Cruse CW, Rappaport D, et al.  Intraoperative radiolymphoscintigraphy improves sentinel node identification for patients with melanoma. Ann Surg. 1996;223:217–224
  16. Leong SPL, Steinmetz I, Habib FA, et al.  Optimal selective lymph node dissection in primary malignant melanoma. Arch Surg. 1997;132:666–672
  17. Balch CM, Buzaid CA, Atkins MB, et al.  A New American Joint Committee on Cancer Staging System for Cutaneous Melanoma. Cancer. 2000;88:1484–1491
  18. Statius Muller MG, Van Leeuwen PAM, De Lange-De Klerk ESM, et al.  The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer. 2001;91:2401–2408
  19. Miller EJ, Daly JM, Synnestvedt M, et al.  Loco-regional nodal relapse in melanoma. Surg Oncol. 1992;1:333–340
  20. Buzaid AC, Tinoco LA, Jendiroba D, et al.  Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol. 1995;9:2361–2368
  21. Prayer L, Winkelbauer H, Gritzmann N, et al.  Sonography versus palpation in the detection of regional lymph node metastases in patients with malignant melanoma. Eur J Cancer. 1990;7:827–830
  22. Nazarian LN, Alexander AA, Nandkumar MR, et al.  Malignant melanoma: Impact of superficial US on mangement. Radiology. 1996;199:273–277
  23. Binder M, Kittler H, Steiner A, et al.  Lymph node sonography versus palpation for detection of recurrent disease in patients with malignant melanoma. Eur J Cancer. 1997;33:1805–1808
  24. Rossi CR, Seno A, Vecciato A, et al.  The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur J Cancer. 1997;3:200–203
  25. Voit C, Mayer T, Proebstle TM, et al.  Ultrasound guided fine needle aspiration cytology (FNAC) in the early detection of melanoma metastases. Cancer. 2000;90:186–193
  26. Voit C, Mayer T, Kron M, et al.  Efficacy of ultrasound B-scan compared with physical examination in Follow-up of melanoma patients. Cancer. 2001;91:2409–2416
  27. Vassallo P, Wranacke K, Roos N, et al.  Differentiation of benign from malignant superficial lymphadenopathy: the role of high resolution US. Radiology. 1992;183:215–220
  28. Alexander AA, Nazarian LN, Capuzzi DM, et al.  Color Doppler sonographic detection of tumor flow in superficial melanoma metastases: Histologic correlation. J Ultrasound Med. 1998;17:123–126
  29. Nazarian LN, Alexander AA, Kurtz AB, et al.  Superficial melanoma metastases: Appearancec on gray-scale and color doppler sonography. Am J Roentgenol. 1998;170:459–463
  30. Vassallo P, Edel G, Roos N, et al.  In-vitro high-resolution ultrasonography of benign and malignant lymph nodes. A sonographic-pathologic correlation. Invest Radiol. 1993;28:698–705
  31. Ulrich J, Voit C. Ultrasound in dermatology. Part II. Ultrasound of regional lymph node basins and subcutaneous tumours. Eur J Dermatol. 2001;11:73–79
  32. Wu CH, Hsu MM, Chang YL, et al.  Vascular pathology of malignant cervical lymphadenopathy. Cancer. 1998;83:1189–1196
  33. Moehrle M, Blum A, Rassner G, et al.  Lymph node metastases of cutaneous melanoma: Diagnosis by B-scan and color Doppler sonography. J Am Acad Dermatol. 1999;41:703–709
  34. Miyauchi S, Tada M, Miki Y. Echographic evaluation of nodular lesions of the skin. J Dermatol. 1983;10:221–227
  35. Nessi R, Betti R, Bencini PL, et al.  Ultrasonography of nodular and infiltrative lesions of the skin and subcutaneous tissues. J Clin Ultrasound. 1990;18:103–109
  36. Ulrich J, Gollnick H. Differential diagnosis of cutaneous and subcutaneous tumours assessed by 7.5 MHz ultrasonography. J Eur Acad Dermatol Venereol. 1999;12:187–189
  37. Perry DP, Seigler HF, Johnston MW. Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: A clinical and pathologic correlation of 298 cases. J Natl Cancer Inst. 1986;77:1013–1021
  38. Basler GD, Fader DJ, Yahanda A, et al.  The utility of fine needle aspirations in the diagnosis of melanoma metastatic to lymph nodes. J Am Acad Dermatol. 1997;36:403–408
  39. Fornage BD, Lorigan JG. Sonographic detection and fine-needle aspiration biopsy of non-palpable recurrent or metastatic melanoma in subcutaneous fatty tissues. J Ultrasound Med. 1989;8:421–424
  40. Layfield LJ, Ostrzega N. Fine needle aspirate smear morphology in metastatic melanoma. Acta Cytol. 1989;33:606–612
  41. Schoengen A, Binder T, Schiffelholz W, et al.  Fine-needle aspiration guided by ultrasound in suspected cancer. Onkologie. 1994;17:420–426
  42. Schoengen A, Binder T, Faiss S, et al.  Feinnadelaspirationszytologie beim metastasierenden malignen Melanom. Verbesserung der Ergebnisse durch Ultraschallführung. Hautarzt. 1993;44:703–707
  43. Binder T. Feinnadelaspirationszytologie: Verbesserte Punktionstechnik mit einem neuen Aspirationsgerät. Tumor Diagn Ther. 1987;8:36–39
  44. Voit C, Kron M, Schwürzer M, et al.  Ultrasound guided fine needle aspiration cytology (FNAC) for early verification of melanoma. Proc Am Soc Clin Oncol. 2001;20:360a; (abstr)
  45. Schwürzer-Voit M, Proebstle TM, Sterry W. Identification of lymph node metastases by use of PCR in melanoma patients. Eur J Cancer. 1996;32:264–268
  46. Voit C, Schoengen A, Weber L, et al.  Identification of melanoma metastases by tyrosinase-reverse transcription-polymerase chain reaction of fine needle aspirates. J Am Acad Dermatol. 1998;39:1030–1032
  47. Voit C, Schoengen A, Schwürzer M, et al.  Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine needle aspirates. Br J Cancer. 1999;80:1672–1677
  48. Panelli MC, Riker A, Kammula U, et al.  Expansion of tumor T-cell pairs from FN aspirates of melanoma metastases. J Immunol. 2000;164:495–504
  49. Riker AL, Panelli MC, Kammula US, et al.  Development and characterization of melanoma cell lines established by FNA biopsy: Advances in monitoring patients with malignant melanoma. Cancer Detect Prev. 1999;23:387–396
  50. Rodriguez LK, Habib FA, Wilson M, et al.  Resection of metastatic melanoma following wire localization guided by computed tomography or ultrasound. Melanoma Res. 1999;9:595–598
  51. Voit C, Proebstle TM, Winter H, et al.  Presurgical ultrasound-guided anchor-wire marking of soft tissue metastases in stage III melanoma patients. Dermatol Surg. 2001;27:129–132
  52. Feun LG, Guttermann J, Burgess MA, et al.  The natural history of resectable metastatic melanoma (stage IVA melanoma). Cancer. 1982;50:1656–1663
  53. Wong JH, Skinner KA, Kim KA, et al.  The role of surgery in the treatment of nonregionally recurrent melanoma. Surgery. 1993;113:389–394
  54. Wornom IL, Soong SJ, Urist MM, et al.  Surgery as palliative treatment for distant metastases of melanoma. Ann Surg. 1986;204:181–185
  55. Ryan L, Kramar A, Borden E. Prognostic factors in metastatic melanoma. Cancer. 1993;71:2995–3005
  56. Ollila DW, Hsueh EC, Stern SL, Morton DL. Metastatectomy for recurrent stage IV melanoma. J Surg-Oncol. 1999;71:209–213
  57. Agrawala S, Yao TJ, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol. 1999;6:336–344
  58. Blum A, Schlagenhauff B, Stroebel W, et al.  Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous disease. Cancer. 2000;88:2534–2539

 Address reprint requests to Christiane Voit, MD, Department of Dermatology, Charité, Humboldt University, Schumannstr. 20/21, 10117 Berlin, Germany.

PII: S0093-7754(02)50265-7

doi: 10.1053/sonc.2002.34113

Seminars in Oncology
Volume 29, Issue 4 , Pages 353-360 , August 2002